Scott Applebaum - Net Worth and Insider Trading

Scott Applebaum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Applebaum owns 4 companies in total, including Trevena Inc (TRVN) , Vitae Pharmaceuticals Inc (VTAE) , and Aevi Genomic Medicine Inc (GNMX) among others .

Click here to see the complete history of Scott Applebaum’s form 4 insider trades.

Insider Ownership Summary of Scott Applebaum

Ticker	Comapny	Transaction Date	Type of Owner
TRVN	Trevena Inc	2020-12-17	CLCO; SVP & Regulatory Affairs
VTAE	Vitae Pharmaceuticals Inc	2016-10-25	General Counsel
GNMX	Aevi Genomic Medicine Inc	2016-04-15	Chief Legal Officer
		2022-08-09	director

Scott Applebaum Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Scott Applebaum Ownership Network

Ownership Network List of Scott Applebaum

No Data

Ownership Network Relation of Scott Applebaum

Scott Applebaum Owned Company Details

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Scott Applebaum is the CLCO; SVP & Regulatory Affairs of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Scott Applebaum is the General Counsel of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , Chief Medical Officer Carole Sable , and director & Chief Executive Officer Jeffrey S. Hatfield .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aevi Genomic Medicine Inc do?

Who are the key executives at Aevi Genomic Medicine Inc?

Scott Applebaum is the Chief Legal Officer of Aevi Genomic Medicine Inc. Other key executives at Aevi Genomic Medicine Inc include director & Chief Executive Officer Michael F Cola , Chief Scientific Officer Garry Arthur Neil , and 10 percent owner Plc Astrazeneca .

Aevi Genomic Medicine Inc (GNMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aevi Genomic Medicine Inc (GNMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aevi Genomic Medicine Inc (GNMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aevi Genomic Medicine Inc (GNMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aevi Genomic Medicine Inc Insider Transactions

No Available Data

What does Cingulate Inc do?

Who are the key executives at Cingulate Inc?

Scott Applebaum is the director of Cingulate Inc. Other key executives at Cingulate Inc include Corporate Controller Jennifer L. Callahan , director & 10 percent owner Peter J. Werth , and director & 10 percent owner & Chief Executive Officer Shane J. Schaffer .

Cingulate Inc (CING) Insider Trades Summary

Over the past 18 months, Scott Applebaum made no insider transaction in Cingulate Inc (CING). Other recent insider transactions involving Cingulate Inc (CING) include a net purchase of 18,548 shares made by Jennifer L. Callahan , a net purchase of 1,852,089 shares made by Peter J. Werth , and a net purchase of 25,000 shares made by Shane J. Schaffer .

In summary, during the past 3 months, insiders sold 0 shares of Cingulate Inc (CING) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cingulate Inc (CING) were sold and 94,782 shares were bought by its insiders, resulting in a net purchase of 94,782 shares.

Cingulate Inc (CING)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cingulate Inc Insider Transactions

No Available Data

Scott Applebaum Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Applebaum. You might contact Scott Applebaum via mailing address: C/o Trevena Inc., 955 Chesterbrook Boulevard, Suite 110, Chesterbrook Pa 19087.

Discussions on Scott Applebaum

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.